BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2260930)

  • 1. [Posture and circadian variations in serum theophylline concentrations].
    Kishida M; Hukushima K; Iikura Y
    Arerugi; 1990 Oct; 39(10):1422-6. PubMed ID: 2260930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL; Sette L; Vallone G; Plebani M; Messori A
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of theophylline and circadian rhythm].
    Pradalier A; Dry J; Flouvat B; Decourt S; Fodor F
    Pathol Biol (Paris); 1982 Dec; 30(10):851-4. PubMed ID: 6760063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of theophylline chronokinetics for asthmatic children.
    Smolensky MH; Scott PH; McGovern JP
    Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S; Baillie E
    J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.